JPRN-UMIN000017687已完成未知
Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from tafluprost 0.0015% monotherapy. - Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from tafluprost 0.0015% monotherapy.
Department of Ophthalmology, Keio University School of Medicine0 个研究点目标入组 50 人开始时间: 2015年5月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •# Angle closure # History of glaucoma surgery # Bronchial asthma
研究者
相似试验
已完成
3 期
The effect of latanoprost for the treatment of patient with scalp patchy alopeciaAlopecia areataAlopecia areata.IRCT20090813002342N11Mazandaran University of Medical Sciences30
已完成
不适用
Switch Studychronic constipationJPRN-jRCTs031200168Masaki Maruyama106
招募中
不适用
Efficacy and safety of switching from febuxostat to dotinurad, a novel selective urate reabsorption inhibitor, in hyperuricemic patients with type 2 diabetes kidney diseasediabetic kidney disease, HyperuricemiaD033461, D003928HyperuricemiaJPRN-jRCTs031220080Osonoi Takeshi50
Unknown
2 期
Latanoprost for the Treatment of Menière's DiseaseMenière's DiseaseNCT01973114Synphora AB100
招募中
不适用
Assessing the efficacy of changing to Travoprost/Timolol fixed combination, as replacement therapy in patients on prostaglandin monotherapyGlaucomaJPRN-UMIN000007028I.CHANGE study group180